As a complex and heterogeneous condition, breast cancer manifests through various molecular subtypes, with hormone receptor-positive (HR+) breast cancer constituting the predominant molecular subtype, representing nearly 70% of all breast cancer cases (2). This evidence concerns the gene NR4A1 and breast carcinoma.